Mark Bandyk, MD
Urology · Lakeland, FLNPI 1790778009
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Edwards Lifesciences at 28.8% of the total. Reporting peaked in 2022 at $491 and has fallen 82.8% since, to $85 in 2024. That places this record below the midpoint for urology clinicians in FL, where the typical reported total is $3,881.
Across 13 payments — averaging $87.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$326
- Boston Scientific$250
- Astellas Pharma US Inc$164
- Urogen Pharma, Inc.$159
- Johnson & Johnson$108
- Ambu Inc.$85
- plus $40 from 2 others
Across 54 payments — averaging $4163.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$224K
- E.r. Squibb & Sons, L.L.C.$598
What the payments were for
- Food & beverage$1,131100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 2 | $326 |
| Boston Scientific | 4 | $250 |
| Astellas Pharma US Inc | 2 | $164 |
| Urogen Pharma, Inc. | 1 | $159 |
| Johnson & Johnson | 1 | $108 |
| Ambu Inc. | 1 | $85 |
| Coloplast | 1 | $21 |
| Cook Medical LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,131 in reported general payments places this provider in the 25th percentile of 935 urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 216 | $2,743 |
| Solifenacin Succinate | 44 | $2,615 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 62 | $1,456 |
| Finasteride | 60 | $1,215 |
| Doxazosin Mesylate | 78 | $635 |
| NitrofurantoinNitrofurantoin Macrocrystal | 17 | $328 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 41 | $114 |
| Ciprofloxacin Hcl | 18 | $70 |
| Terazosin Hcl | 13 | $27 |
Paid to pharmacies, not to this prescriber.
Other urology in Lakeland
- Paul PeritoCoral Gables$3.6M
- Scott SellingerTallahassee$2.3M
- Mark Anthony GonzalgoMiami$1M
- Edward GheilerHialeah$655K
- Rolando RiveraNaples$437K
- Matthew ErcolaniVenice$416K
- Olubayo TojuolaOrlando$283K
- Juan SuarezCoral Gables$276K
- Michael McDonaldCelebration$272K
- Raymond PakJacksonville$251K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.